$48.63
+0.410 (+0.85%)
At Close: Jul 28, 2026
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
07:35am, Tuesday, 21'st Jul 2026
Novo Nordisk filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed to mislead consumers about their superior efficacy r
Citi lifts Novo Nordisk target on strong GLP-1 pill launch
09:35am, Monday, 20'th Jul 2026
Citi has raised its price target on Novo Nordisk (NYSE:NVO) to DKK330 ahead of second-quarter results on 5 August, citing the strength of the Danish drugmaker's Wegovy pill launch. The broker lifted i
One in Every Five U.S. Homes Using GLP-1s: What it Means for Consumer Trends
04:00pm, Saturday, 18'th Jul 2026
MichaelAaron Flicker examines the growing impact of GLP-1 medications on consumer behavior, noting that roughly one in five American households has someone using a GLP-1 drug. He explains how that tre
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
03:45pm, Saturday, 18'th Jul 2026
Viking Therapeutics just launched its next-gen weight loss program. Novo Nordisk and Eli Lilly are already deep into the development process with comparable programs.
Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win
02:30pm, Friday, 17'th Jul 2026
Novo Nordisk is pulling ahead of Eli Lilly in the market for oral weight loss medicines. Eli Lilly has several tricks up its sleeve that could help it make some progress in this niche.
3 Refining & Marketing MLPs With Strong Industry Tailwinds
10:36am, Thursday, 16'th Jul 2026
Following a careful analysis of the Zacks Oil and Gas - Refining & Marketing MLP industry, we advise keeping an eye on three stocks: SPH, NGL and GLP.
Fractyl Health Says Revita Helped Patients Keep Weight Off After Stopping GLP-1s
09:03am, Wednesday, 15'th Jul 2026
Fractyl Health NASDAQ: GUTS reported one-year data from the randomized midpoint cohort of its REMAIN-1 study, saying its Revita procedure helped patients maintain a larger share of GLP-1-induced weigh
Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with sham at one year in patients receiving complete duodenal ablations Next anticipated Revita® milestones are topline six-mo
Study flags need to monitor frailty risks with GLP-1 drugs for older adults
07:08pm, Tuesday, 14'th Jul 2026
Potential signs of frailty in older adults taking Eli Lilly's GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study that underscores concerns
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
08:30am, Tuesday, 14'th Jul 2026
Highlights An unclaimed opportunity. Large-volume body contouring, and restoration of the breasts, hips, and buttocks is a significant injectable aesthetics category yet to be claimed.
Poolbeg Pharma raises £3.5m to support key trial and GLP-1 progress
02:46am, Tuesday, 14'th Jul 2026
Poolbeg Pharma PLC (AIM:POLB), the clinical-stage biopharmaceutical, has raised £3.5 million before expenses through a share placing. Cathal Friel, executive chair, subscribed for £250,000 of the p
- Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveragi
Top-tier U.S. grocery and pharmacy chain launches 662-store GLP-1 pharmacy merchandising One of North America's largest omnichannel retailers approves onboarding of Rejuvenate's complete eight-SKU por
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
08:00am, Saturday, 11'th Jul 2026
Vivani Medical believes a tiny implant placed under the skin could help address the biggest issue with blockbuster GLP-1s: keeping patients on treatment to maintain their weight loss. The biotech comp
Plus, how fitness trackers stack up against each other and the popularity of panic pouches.
Sign In
Buy GLP